Case report: Sandwich therapy of CAR-T combined with ASCT: Sequential CAR-T cell therapy with ASCT after remission with CAR-T therapy caused long-term survival in a patient with relapsed/refractory…

Overview of attention for article published in Frontiers in immunology, March 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

So far, Altmetric has seen 1 news story.

许多研究最近揭示了TP53突变是接受标准化疗的患者的独立预后指标。携带TP53突变的BL患者可能无法从强化化疗、单独ASCT或其他靶向治疗策略中获益。携带TP53突变的伯基特淋巴瘤（BL）经标准化疗免疫治疗后通常预后不佳。过继性嵌合抗原受体T（CAR-T…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.